Guardian Pharmacy Services (NYSE:GRDN) Trading Down 6.9% – Here’s What Happened

Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) fell 6.9% on Friday . The stock traded as low as $27.70 and last traded at $27.46. 232,289 shares traded hands during mid-day trading, a decline of 16% from the average session volume of 274,956 shares. The stock had previously closed at $29.50.

Analyst Ratings Changes

A number of analysts have recently weighed in on the stock. Truist Financial raised their price target on shares of Guardian Pharmacy Services from $30.00 to $34.00 and gave the company a “buy” rating in a report on Friday, November 14th. Wall Street Zen raised shares of Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a research report on Monday, November 17th. Weiss Ratings restated a “hold (c+)” rating on shares of Guardian Pharmacy Services in a research note on Monday, December 29th. Oppenheimer assumed coverage on Guardian Pharmacy Services in a report on Friday, October 10th. They set an “outperform” rating and a $30.00 target price on the stock. Finally, Stephens boosted their price target on Guardian Pharmacy Services from $35.00 to $36.00 and gave the company an “overweight” rating in a report on Wednesday. Four research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $32.00.

Guardian Pharmacy Services Stock Performance

The company has a 50 day simple moving average of $29.99 and a 200 day simple moving average of $26.39. The company has a market capitalization of $1.71 billion, a PE ratio of 42.75 and a beta of 0.96.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings results on Monday, November 10th. The company reported $0.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.24 by $0.01. The firm had revenue of $377.43 million for the quarter, compared to analyst estimates of $381.16 million. Guardian Pharmacy Services had a return on equity of 30.29% and a net margin of 2.90%. As a group, equities research analysts anticipate that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current year.

Institutional Investors Weigh In On Guardian Pharmacy Services

A number of large investors have recently made changes to their positions in the stock. SG Americas Securities LLC increased its holdings in shares of Guardian Pharmacy Services by 274.9% in the fourth quarter. SG Americas Securities LLC now owns 19,017 shares of the company’s stock valued at $572,000 after purchasing an additional 13,945 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in Guardian Pharmacy Services by 31.1% in the 3rd quarter. JPMorgan Chase & Co. now owns 7,899 shares of the company’s stock valued at $207,000 after buying an additional 1,872 shares in the last quarter. Voleon Capital Management LP acquired a new stake in shares of Guardian Pharmacy Services in the 3rd quarter worth $692,000. Qube Research & Technologies Ltd purchased a new position in shares of Guardian Pharmacy Services during the 3rd quarter worth $2,526,000. Finally, Millennium Management LLC boosted its position in shares of Guardian Pharmacy Services by 725.2% during the 3rd quarter. Millennium Management LLC now owns 342,038 shares of the company’s stock valued at $8,972,000 after acquiring an additional 300,587 shares during the last quarter.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.